OTT: FACBC: The Journey @emoryuniversity
OTT: FACBC: The Journey  @emoryuniversity
Uploaded May 2022 | Updated November 2026, 2 days ago
Waiting twenty years for your discovery to gain FDA approval might test some researchers' resolve. But Mark Goodman, kept his eye on the prize: a new and improved imaging agent. We created a molecule, FACBC, and studied it in cancer cell. We discovered that the radiotracer was especially good for looking at prostate cancer and superior to the current imaging agent. With the construction of a new research building and radiopharmacy lab inventor meets patient.

Learn more here: https://www.ott.emory.edu/about/success/axumin.html
OTT: FACBC: The JourneyOTT: Annual Celebration: 2022 Significant Event of the YearOxford Launch: LondonThe Gilded Age and Historical Accuracy -Executive Producer and #emory professor Dr. Dunbar2026 Raymond Danowski Poetry Library Reading featuring Danez SmithEmory Libraries Preservation DepartmentEmory University Welcomes You to AtlantaEmory Move In 2023From Social Death, Laboratory Life: Race, Diabetes, and the Science of InclusionOxford Olympics 2023Emory Neuroscience Phd Student & Decathlon World Champion Nikki BoonHow multicellular life may have evolved
Emory University |

OTT: FACBC: The Journey

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER